Design
Editorial
Answers are grounded in this paper and cite their sources.
A summary of key presentations on atrial fibrillation ablation from the Heart Rhythm Society 2018 Scientific Sessions, including the CABANA trial.
Earlier this year in Boston, the world of cardiac rhythm management was focused on the annual Scientific Sessions of the Heart Rhythm Society. I think it is fair to say that atrial fibrillation (AF) ablation stole the show. With the presentation of the Catheter Ablation versus Antiarrhythmic Drug Therapy for AF (CABANA) trial, the most anxiously anticipated trial in recent years, and many other important contributions from large multicenter trials, catheter ablation for AF was at the center of the cardiology world. Let us get right to it.
No takes yet. Share an insight, caveat, or question.
Rahul N. Doshi (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: